Literature DB >> 25182364

LBVS: an online platform for ligand-based virtual screening using publicly accessible databases.

Minghao Zheng1, Zhihong Liu, Xin Yan, Qianzhi Ding, Qiong Gu, Jun Xu.   

Abstract

Abundant data on compound bioactivity and publicly accessible chemical databases increase opportunities for ligand-based drug discovery. In order to make full use of the data, an online platform for ligand-based virtual screening (LBVS) using publicly accessible databases has been developed. LBVS adopts Bayesian learning approach to create virtual screening models because of its noise tolerance, speed, and efficiency in extracting knowledge from data. LBVS currently includes data derived from BindingDB and ChEMBL. Three validation approaches have been employed to evaluate the virtual screening models created from LBVS. The tenfold cross validation results of twenty different LBVS models demonstrate that LBVS achieves an average AUC value of 0.86. Our internal and external testing results indicate that LBVS is predictive for lead identifications. LBVS can be publicly accessed at http://rcdd.sysu.edu.cn/lbvs.

Mesh:

Substances:

Year:  2014        PMID: 25182364     DOI: 10.1007/s11030-014-9545-3

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  50 in total

1.  A new approach to finding natural chemical structure classes.

Authors:  Jun Xu
Journal:  J Med Chem       Date:  2002-11-21       Impact factor: 7.446

2.  Assessing different classification methods for virtual screening.

Authors:  Dariusz Plewczynski; Stéphane A H Spieser; Uwe Koch
Journal:  J Chem Inf Model       Date:  2006 May-Jun       Impact factor: 4.956

Review 3.  Structure-based drug screening and ligand-based drug screening with machine learning.

Authors:  Yoshifumi Fukunishi
Journal:  Comb Chem High Throughput Screen       Date:  2009-05       Impact factor: 1.339

4.  Ligand-target prediction using Winnow and naive Bayesian algorithms and the implications of overall performance statistics.

Authors:  Florian Nigsch; Andreas Bender; Jeremy L Jenkins; John B O Mitchell
Journal:  J Chem Inf Model       Date:  2008-12       Impact factor: 4.956

5.  Discovery of new inhibitors of Mycobacterium tuberculosis InhA enzyme using virtual screening and a 3D-pharmacophore-based approach.

Authors:  Ivani Pauli; Ricardo N dos Santos; Diana C Rostirolla; Leonardo K Martinelli; Rodrigo G Ducati; Luís F S M Timmers; Luiz A Basso; Diógenes S Santos; Rafael V C Guido; Adriano D Andricopulo; Osmar Norberto de Souza
Journal:  J Chem Inf Model       Date:  2013-08-20       Impact factor: 4.956

6.  GSA: a GPU-accelerated structure similarity algorithm and its application in progressive virtual screening.

Authors:  Xin Yan; Qiong Gu; Feng Lu; Jiabo Li; Jun Xu
Journal:  Mol Divers       Date:  2012-10-19       Impact factor: 2.943

Review 7.  Virtual screening strategies in drug discovery: a critical review.

Authors:  A Lavecchia; C Di Giovanni
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

8.  Discovery of new selective human aldose reductase inhibitors through virtual screening multiple binding pocket conformations.

Authors:  Ling Wang; Qiong Gu; Xuehua Zheng; Jiming Ye; Zhihong Liu; Jiabo Li; Xiaopeng Hu; Arnold Hagler; Jun Xu
Journal:  J Chem Inf Model       Date:  2013-08-26       Impact factor: 4.956

9.  Chemical substructures that enrich for biological activity.

Authors:  Justin Klekota; Frederick P Roth
Journal:  Bioinformatics       Date:  2008-09-10       Impact factor: 6.937

10.  Full "Laplacianised" posterior naive Bayesian algorithm.

Authors:  Hamse Y Mussa; John Bo Mitchell; Robert C Glen
Journal:  J Cheminform       Date:  2013-08-23       Impact factor: 5.514

View more
  4 in total

1.  DeepScreening: a deep learning-based screening web server for accelerating drug discovery.

Authors:  Zhihong Liu; Jiewen Du; Jiansong Fang; Yulong Yin; Guohuan Xu; Liwei Xie
Journal:  Database (Oxford)       Date:  2019-01-01       Impact factor: 3.451

2.  Computational prediction of potential inhibitors for SARS-COV-2 main protease based on machine learning, docking, MM-PBSA calculations, and metadynamics.

Authors:  Isabela de Souza Gomes; Charles Abreu Santana; Leandro Soriano Marcolino; Leonardo Henrique França de Lima; Raquel Cardoso de Melo-Minardi; Roberto Sousa Dias; Sérgio Oliveira de Paula; Sabrina de Azevedo Silveira
Journal:  PLoS One       Date:  2022-04-22       Impact factor: 3.752

3.  AlzhCPI: A knowledge base for predicting chemical-protein interactions towards Alzheimer's disease.

Authors:  Jiansong Fang; Ling Wang; Yecheng Li; Wenwen Lian; Xiaocong Pang; Hong Wang; Dongsheng Yuan; Qi Wang; Ai-Lin Liu; Guan-Hua Du
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

4.  DenovoProfiling: A webserver for de novo generated molecule library profiling.

Authors:  Zhihong Liu; Jiewen Du; Ziying Lin; Ze Li; Bingdong Liu; Zongbin Cui; Jiansong Fang; Liwei Xie
Journal:  Comput Struct Biotechnol J       Date:  2022-08-02       Impact factor: 6.155

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.